October 13, 2025Open Access

Augmented orexin/hypocretin signaling underlies negative affect during acute oxycodone abstinence in rats.

View Full Paper

Ask AI

Bookmark

Chronic oxycodone use leads to a negative affective state during withdrawal, including signs such as weight loss and anxiety.
Enhanced activity of orexin neurons during abstinence correlates with the severity of negative affect experienced by the rats.
Modulating orexin neurons using chemogenetics showed promise in reducing the development of negative affective symptoms during withdrawal.
Targeting the orexin system may offer new treatment strategies for managing withdrawal symptoms in individuals with opioid use disorder.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This study demonstrates a link between orexin signaling and negative affect during oxycodone withdrawal, suggesting potential treatment pathways for opioid use disorder.

Cite This Study

Aston‐Jones et al. (2025) studied this question.

synapsesocial.com/papers/68ed4e04d3b1bfa344c60171 https://doi.org/10.21203/rs.3.rs-7652324/v1

View Full Paper

Ask AI

Bookmark

Implication

This study demonstrates a link between orexin signaling and negative affect during oxycodone withdrawal, suggesting potential treatment pathways for opioid use disorder.

Augmented orexin/hypocretin signaling underlies negative affect during acute oxycodone abstinence in rats.

Key Points

Discussion

Implication

Cite This Study

Augmented orexin/hypocretin signaling underlies negative affect during acute oxycodone abstinence in rats.

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading